Corestemchemon (XKRX:166480) Total Tax Payable : ₩0 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Corestemchemon Total Tax Payable?

Corestemchemon's Total Tax Payable for the quarter that ended in Sep. 2024 was ₩0 Mil.

Corestemchemon's annual Total Tax Payable increased from Dec. 2021 (₩718 Mil) to Dec. 2022 (₩1,767 Mil) but then declined from Dec. 2022 (₩1,767 Mil) to Dec. 2023 (₩0 Mil).

Corestemchemon Total Tax Payable Historical Data

The historical data trend for Corestemchemon's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corestemchemon Total Tax Payable Chart

Corestemchemon Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

685.31

2,283.56

717.89

1,766.86

Corestemchemon Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															265.88	-	-	-	-

Corestemchemon Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Corestemchemon Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Corestemchemon's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Corestemchemon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corestemchemon Inc (XKRX:166480) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pangyo 255 beongil 24 I & C Building, 2nd Floor, yeonggi-do, Bundang-gu, Seongnam, Seoul, KOR, 13486

Website

http://www.corestemchemon.com

Corestemchemon Inc is a biopharmaceutical company that researches and commercializes stem cell technology. It has developed NEURONATA-R inj., a stem cell therapy for Lou Gehrig's disease which is a rare incurable disease, for the first ALS treatment. Its stem cell therapeutics for Lou Gehrig's disease have a pipeline of incurable diseases such as lupus, multiple system atrophy, and osteoarthritis, and plans to preoccupy the market by focusing on developing therapies for rare incurable diseases based on a development success reference of stem cell therapy for the Lou Gehrig's disease.

Corestemchemon Headlines

No Headlines